Ocular Therapeutix, Inc.
$9.87
-$0.32 (-3.14%)
$9.81Day Range$10.32
Key Statistics
Market Cap
$2.17B
Shares Outstanding
219.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 25, 2014
Round Lot
100
Locale
US
Trading Data
Day Open
$10.21
Day High
$10.32
Day Low
$9.81
Volume
3.41M
VWAP
$10.04
Prev Close
$10.19
Transactions
--
Acc. Volume
--
About Ocular Therapeutix, Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
PHARMACEUTICAL PREPARATIONSSIC 2834325 employees14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730781-357-4000IPO Jul 25, 2014US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001393434
- Composite FIGI
- BBG001J1BZV0
- Share Class FIGI
- BBG001V0FT93
- Ticker Root
- OCUL
- SIC Code
- 2834
About Ocular Therapeutix, Inc. (OCUL) Stock
Ocular Therapeutix, Inc. (OCUL) closed the 2026-09-16 session at $9.87, down 3.14% versus the previous close (-0.32). The stock opened at $10.21 and traded between $9.81 and $10.32 during that session. Session trading volume was 3.4M shares. The volume-weighted average price (VWAP) is $10.04.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Ocular Therapeutix, Inc. has a market capitalization of $2.17 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. OCUL is listed on the XNAS exchange. The company employs approximately 325 people. Ocular Therapeutix, Inc. is headquartered in BEDFORD, MA. The recorded listing date is 2014-07-25.
On this page you can find market OCUL stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.